Profound Medical Appoints Arun Menawat as CEO

Ontario Industry Updates
Written By Guest User

Aug 15, 2016 - Toronto: Profound Medical Corp. (TSXV:PRN), an emerging medical device company focused on prostate cancer care, today announced the appointment of Arun Menawat, Ph.D. as its new Chief Executive Officer.  Steven Plymale, the Company’s current CEO, will transition to President and Chief Operating Officer.

For the full press release, click here

Guest User
Previous

Trillium Therapeutics Receives FDA Clearance to Proceed With TTI-621 in Clinical Trial Targeting Solid Tumors and Mycosis Fungoides
Next

CAAP Company: Eve Medical Wins "The Next 36" Alumni Achievement Award